Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

Davis D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ.

Br J Rheumatol. 1997 Sep;36(9):950-6.

PMID:
9376990
2.

[The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis].

Zhu Y, Ye D, Huang Z.

Zhonghua Xue Ye Xue Za Zhi. 2000 Nov;21(11):587-90. Chinese.

PMID:
11225250
4.

Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease.

Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ.

J Rheumatol. 1997 Aug;24(8):1504-9.

PMID:
9263142
5.
6.
7.
8.

Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.

Ohshima S, Mima T, Sasai M, Nishioka K, Shimizu M, Murata N, Yoshikawa H, Nakanishi K, Suemura M, McCloskey RV, Kishimoto T, Saeki Y.

Cytokine. 2000 Mar;12(3):281-8.

PMID:
10704256
10.

[Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].

Poveda Gómez F, Camacho Siles J, Quevedo Morales E, Fernández Zamorano A, Codoceo Alquinta R, Arnalich Fernández F, Sempere Alcocer M.

An Med Interna. 2001 Jun;18(6):298-304. Spanish.

PMID:
11503575
11.

In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.

Lorenz HM, Grünke M, Hieronymus T, Antoni C, Nüsslein H, Schaible TF, Manger B, Kalden JR.

J Rheumatol. 2000 Feb;27(2):304-10.

PMID:
10685789
12.
13.

Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis.

Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA.

Clin Immunol. 1999 Aug;92(2):153-60.

PMID:
10444359
14.

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M.

Immunol Rev. 1995 Apr;144:195-223. Review.

PMID:
7590814
16.

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis.

Rankin EC, Choy EH, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, Panayi GS.

Br J Rheumatol. 1995 Apr;34(4):334-42.

PMID:
7788147
17.

Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.

Capocasale RJ, Makropoulos DA, Achuthanandam R, Stowell N, Quinn J, Rafferty PA, O'Brien J, Emmell E, Bugelski PJ.

Cytometry A. 2008 Feb;73(2):148-59. doi: 10.1002/cyto.a.20512.

18.

The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis.

Vreugdenhil G, Swaak AJ.

Clin Rheumatol. 1990 Mar;9(1):22-7. Review.

PMID:
2185909
19.

The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera.

Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T.

Rheumatology (Oxford). 2002 Mar;41(3):329-37.

PMID:
11934972
20.

Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis.

Vreugdenhil G, Löwenberg B, Van Eijk HG, Swaak AJ.

Eur J Clin Invest. 1992 Jul;22(7):488-93.

PMID:
1516597

Supplemental Content

Support Center